Monte Rosa Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Monte Rosa Therapeutics

12/08/2021 15:37

* Monte Rosa Therapeutics Inc  GLUE.OQ  reported a quarterly
adjusted loss of $3.63​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 40 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Monte Rosa Therapeutics Inc's reported EPS for the quarter was
a loss of $3.63​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Monte Rosa Therapeutics Inc shares had risen by 47.8% this
quarter.
* The company reported a quarterly loss of $18.41 million.
* Wall Street's median 12-month price target for Monte Rosa
Therapeutics Inc is $35.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 02:37 p.m.  ​All
figures in US dollars unless otherwise stated